CLINICAL_TRIALS
trial_result
· 2018-12-28
Clinical Trial Update: HIV Protease Inhibitors for the Prevention of Malaria in Ugandan Children [Phase 3]
Summary
Phase 3 trial evaluating HIV protease inhibitors for prevention of malaria in Ugandan children has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of California, San Francisco | Conditions: Malaria, HIV Infections | Phase 3 | Status: COMPLETED | Results posted: 2018-12-28